Abstract

Bioresorbable vascular scaffolds (BVS) have gained significant interest in both the technical and clinical communities as a possible alternative to metallic stents. For accurate BVS analysis, intravascular optical coherence tomography (IVOCT) is currently the most suitable imaging technique due to its high resolution and the translucency of polymeric BVS struts for near infrared light. However, given the large number of struts in an IVOCT pullback run, quantitative analysis is only feasible when struts are detected automatically. In this paper, we present an automated method to detect and measure BVS struts based on their black cores in IVOCT images. Validated using 3 baseline and 3 follow-up data sets, the method detected 93.7% of 4691 BVS struts correctly with 1.8% false positives. In total, the Dice’s coefficient for BVS strut areas was 0.84. It concludes that this method can detect BVS struts accurately and robustly for tissue coverage measurement, malapposition detection, strut distribution analysis or 3D scaffold reconstruction.

© 2014 Optical Society of America

Full Article  |  PDF Article
OSA Recommended Articles
Fully automated side branch detection in intravascular optical coherence tomography pullback runs

Ancong Wang, Jeroen Eggermont, Johan H.C. Reiber, and Jouke Dijkstra
Biomed. Opt. Express 5(9) 3160-3173 (2014)

Automatic analysis of bioresorbable vascular scaffolds in intravascular optical coherence tomography images

Yihui Cao, Qinhua Jin, Yifeng Lu, Jing Jing, Yundai Chen, Qinye Yin, Xianjing Qin, Jianan Li, Rui Zhu, and Wei Zhao
Biomed. Opt. Express 9(6) 2495-2510 (2018)

Automatic stent detection in intravascular OCT images using bagged decision trees

Hong Lu, Madhusudhana Gargesha, Zhao Wang, Daniel Chamie, Guilherme F. Attizzani, Tomoaki Kanaya, Soumya Ray, Marco A. Costa, Andrew M. Rollins, Hiram G. Bezerra, and David L. Wilson
Biomed. Opt. Express 3(11) 2809-2824 (2012)

References

  • View by:
  • |
  • |
  • |

  1. A. Grüntzig, “Transluminal dilatation of coronary-artery stenosis,” Lancet 311(8058), 263 (1978).
    [Crossref] [PubMed]
  2. J. E. Sousa, P. W. Serruys, and M. A. Costa, “New frontiers in cardiology: drug-eluting stents: Part I,” Circulation 107(17), 2274–2279 (2003).
    [Crossref] [PubMed]
  3. B. Kalesan, T. Pilgrim, K. Heinimann, L. Räber, G. G. Stefanini, M. Valgimigli, B. R. da Costa, F. Mach, T. F. Lüscher, B. Meier, S. Windecker, and P. Jüni, “Comparison of drug-eluting stents with bare metal stents in patients with ST-segment elevation myocardial infarction,” Eur. Heart J. 33(8), 977–987 (2012).
    [Crossref] [PubMed]
  4. P. W. Serruys, A. T. Ong, J. J. Piek, F. J. Neumann, W. J. van der Giessen, M. Wiemer, A. Zeiher, E. Grube, J. Haase, L. Thuesen, C. Hamm, and P. C. Otto-Terlouw, “A randomized comparison of a durable polymer Everolimus-eluting stent with a bare metal coronary stent: The SPIRIT first trial,” EuroIntervention 1(1), 58–65 (2005).
    [PubMed]
  5. S. Brugaletta, H. M. Garcia-Garcia, Y. Onuma, and P. W. Serruys, “Everolimus-eluting ABSORB bioresorbable vascular scaffold: present and future perspectives,” Expert Rev. Med. Devices 9(4), 327–338 (2012).
    [Crossref] [PubMed]
  6. C. I. Stefanadis, “Stents for coronary artery disease: from covered to drug-eluting to bioabsorbable., ” Hellenic J. Cardiol. 53(1), 89–90 (2012).
    [PubMed]
  7. D. Dudek, Y. Onuma, J. A. Ormiston, L. Thuesen, K. Miquel-Hebert, and P. W. Serruys, “Four-year clinical follow-up of the ABSORB everolimus-eluting bioresorbable vascular scaffold in patients with de novo coronary artery disease: the ABSORB trial,” EuroIntervention 7(9), 1060–1061 (2012).
    [Crossref] [PubMed]
  8. J. Gomez-Lara, S. Brugaletta, R. Diletti, S. Garg, Y. Onuma, B. D. Gogas, R. J. van Geuns, C. Dorange, S. Veldhof, R. Rapoza, R. Whitbourn, S. Windecker, H. M. Garcia-Garcia, E. Regar, and P. W. Serruys, “A comparative assessment by optical coherence tomography of the performance of the first and second generation of the everolimus-eluting bioresorbable vascular scaffolds,” Eur. Heart J. 32(3), 294–304 (2011).
    [Crossref] [PubMed]
  9. A. Karanasos, C. Simsek, P. Serruys, J. Ligthart, K. Witberg, R. J. van Geuns, G. Sianos, F. Zijlstra, and E. Regar, “Five-year optical coherence tomography follow-up of an everolimus-eluting bioresorbable vascular scaffold: changing the paradigm of coronary stenting?” Circulation 126(7), e89–e91 (2012).
    [Crossref] [PubMed]
  10. P. W. Serruys, J. A. Ormiston, Y. Onuma, E. Regar, N. Gonzalo, H. M. Garcia-Garcia, K. Nieman, N. Bruining, C. Dorange, K. Miquel-Hébert, S. Veldhof, M. Webster, L. Thuesen, and D. Dudek, “A bioabsorbable everolimus-eluting coronary stent system (ABSORB): 2-year outcomes and results from multiple imaging methods,” Lancet 373(9667), 897–910 (2009).
    [Crossref] [PubMed]
  11. P. W. Serruys, Y. Onuma, J. A. Ormiston, B. de Bruyne, E. Regar, D. Dudek, L. Thuesen, P. C. Smits, B. Chevalier, D. McClean, J. Koolen, S. Windecker, R. Whitbourn, I. Meredith, C. Dorange, S. Veldhof, K. Miquel-Hebert, R. Rapoza, and H. M. García-García, “Evaluation of the second generation of a bioresorbable everolimus drug-eluting vascular scaffold for treatment of de novo coronary artery stenosis: six-month clinical and imaging outcomes,” Circulation 122(22), 2301–2312 (2010).
    [Crossref] [PubMed]
  12. A. Sheehy, J. L. Gutiérrez-Chico, R. Diletti, J. P. Oberhauser, T. Glauser, J. Harrington, M. B. Kossuth, R. J. Rapoza, Y. Onuma, and P. W. Serruys, “In vivo characterisation of bioresorbable vascular scaffold strut interfaces using optical coherence tomography with Gaussian line spread function analysis,” EuroIntervention 7(10), 1227–1235 (2012).
    [Crossref] [PubMed]
  13. N. Gonzalo, P. W. Serruys, N. Piazza, and E. Regar, “Optical coherence tomography (OCT) in secondary revascularisation: stent and graft assessment,” EuroIntervention 5(Suppl D), D93–D100 (2009).
    [PubMed]
  14. J. L. Gutiérrez-Chico, M. D. Radu, R. Diletti, A. Sheehy, M. B. Kossuth, J. P. Oberhauser, T. Glauser, J. Harrington, R. J. Rapoza, Y. Onuma, and P. W. Serruys, “Spatial distribution and temporal evolution of scattering centers by optical coherence tomography in the poly(L-lactide) backbone of a bioresorbable vascular scaffold,” Circ. J. 76(2), 342–350 (2012).
    [Crossref] [PubMed]
  15. B. D. Gogas, V. Farooq, Y. Onuma, and P. W. Serruys, “The ABSORB bioresorbable vascular scaffold: an evolution or revolution in interventional cardiology?” Hellenic J. Cardiol. 53(4), 301–309 (2012).
    [PubMed]
  16. S. Gurmeric, G. G. Isguder, S. Carlier, and G. Unal, “A new 3-D automated computational method to evaluate in-stent neointimal hyperplasia in in-vivo intravascular optical coherence tomography pullbacks,” Med. Image Comput. Comput. Assist. Interv. 12(Pt 2), 776–785 (2009).
    [PubMed]
  17. G. Unal, S. Gurmeric, and S. G. Carlier, “Stent implant follow-up in intravascular optical coherence tomography images,” Int. J. Cardiovasc. Imaging 26(7), 809–816 (2010).
    [Crossref] [PubMed]
  18. C. Xu, J. M. Schmitt, T. Akasaka, T. Kubo, and K. Huang, “Automatic detection of stent struts with thick neointimal growth in intravascular optical coherence tomography image sequences,” Phys. Med. Biol. 56(20), 6665–6675 (2011).
    [Crossref] [PubMed]
  19. A. Wang, J. Eggermont, N. Dekker, H. M. Garcia-Garcia, R. Pawar, J. H. C. Reiber, and J. Dijkstra, “A robust automated method to detect stent struts in 3D intravascular optical coherence tomographic image sequences,” Proc. SPIE 8315, 83150L (2012).
    [Crossref]
  20. G. Unal, S. Bucher, S. Carlier, G. Slabaugh, T. Fang, and K. Tanaka, “Shape-driven segmentation of the arterial wall in intravascular ultrasound images,” IEEE Trans. Inf. Technol. Biomed. 12(3), 335–347 (2008).
    [Crossref] [PubMed]
  21. A. Wang, J. Eggermont, N. Dekker, H. M. Garcia-Garcia, R. Pawar, J. H. Reiber, and J. Dijkstra, “Automatic stent strut detection in intravascular optical coherence tomographic pullback runs,” Int. J. Cardiovasc. Imaging 29(1), 29–38 (2013).
    [Crossref] [PubMed]
  22. J. M. S. Prewitt, “Object enhancement and extraction,” in Picture Processing and Psychopictorics, B. S. Lipkin, ed. (Academic Press, New York, 1970), pp. 75–149.
  23. E. W. Dijkstra, “A note on two problems in connexion with graphs,” Numer. Math. 1(1), 269–271 (1959).
    [Crossref]
  24. W. K. Pratt, Digital Image Processing (John Wiley & Sons, Inc., 1978), p. 750.
  25. A. Wang, J. Eggermont, N. Dekker, P. J. de Koning, J. H. Reiber, and J. Dijkstra, “3D assessment of stent cell size and side branch access in intravascular optical coherence tomographic pullback runs,” Comput. Med. Imaging Graph. 38(2), 113–122 (2014).
    [Crossref] [PubMed]

2014 (1)

A. Wang, J. Eggermont, N. Dekker, P. J. de Koning, J. H. Reiber, and J. Dijkstra, “3D assessment of stent cell size and side branch access in intravascular optical coherence tomographic pullback runs,” Comput. Med. Imaging Graph. 38(2), 113–122 (2014).
[Crossref] [PubMed]

2013 (1)

A. Wang, J. Eggermont, N. Dekker, H. M. Garcia-Garcia, R. Pawar, J. H. Reiber, and J. Dijkstra, “Automatic stent strut detection in intravascular optical coherence tomographic pullback runs,” Int. J. Cardiovasc. Imaging 29(1), 29–38 (2013).
[Crossref] [PubMed]

2012 (9)

A. Wang, J. Eggermont, N. Dekker, H. M. Garcia-Garcia, R. Pawar, J. H. C. Reiber, and J. Dijkstra, “A robust automated method to detect stent struts in 3D intravascular optical coherence tomographic image sequences,” Proc. SPIE 8315, 83150L (2012).
[Crossref]

B. Kalesan, T. Pilgrim, K. Heinimann, L. Räber, G. G. Stefanini, M. Valgimigli, B. R. da Costa, F. Mach, T. F. Lüscher, B. Meier, S. Windecker, and P. Jüni, “Comparison of drug-eluting stents with bare metal stents in patients with ST-segment elevation myocardial infarction,” Eur. Heart J. 33(8), 977–987 (2012).
[Crossref] [PubMed]

S. Brugaletta, H. M. Garcia-Garcia, Y. Onuma, and P. W. Serruys, “Everolimus-eluting ABSORB bioresorbable vascular scaffold: present and future perspectives,” Expert Rev. Med. Devices 9(4), 327–338 (2012).
[Crossref] [PubMed]

C. I. Stefanadis, “Stents for coronary artery disease: from covered to drug-eluting to bioabsorbable., ” Hellenic J. Cardiol. 53(1), 89–90 (2012).
[PubMed]

D. Dudek, Y. Onuma, J. A. Ormiston, L. Thuesen, K. Miquel-Hebert, and P. W. Serruys, “Four-year clinical follow-up of the ABSORB everolimus-eluting bioresorbable vascular scaffold in patients with de novo coronary artery disease: the ABSORB trial,” EuroIntervention 7(9), 1060–1061 (2012).
[Crossref] [PubMed]

A. Karanasos, C. Simsek, P. Serruys, J. Ligthart, K. Witberg, R. J. van Geuns, G. Sianos, F. Zijlstra, and E. Regar, “Five-year optical coherence tomography follow-up of an everolimus-eluting bioresorbable vascular scaffold: changing the paradigm of coronary stenting?” Circulation 126(7), e89–e91 (2012).
[Crossref] [PubMed]

A. Sheehy, J. L. Gutiérrez-Chico, R. Diletti, J. P. Oberhauser, T. Glauser, J. Harrington, M. B. Kossuth, R. J. Rapoza, Y. Onuma, and P. W. Serruys, “In vivo characterisation of bioresorbable vascular scaffold strut interfaces using optical coherence tomography with Gaussian line spread function analysis,” EuroIntervention 7(10), 1227–1235 (2012).
[Crossref] [PubMed]

J. L. Gutiérrez-Chico, M. D. Radu, R. Diletti, A. Sheehy, M. B. Kossuth, J. P. Oberhauser, T. Glauser, J. Harrington, R. J. Rapoza, Y. Onuma, and P. W. Serruys, “Spatial distribution and temporal evolution of scattering centers by optical coherence tomography in the poly(L-lactide) backbone of a bioresorbable vascular scaffold,” Circ. J. 76(2), 342–350 (2012).
[Crossref] [PubMed]

B. D. Gogas, V. Farooq, Y. Onuma, and P. W. Serruys, “The ABSORB bioresorbable vascular scaffold: an evolution or revolution in interventional cardiology?” Hellenic J. Cardiol. 53(4), 301–309 (2012).
[PubMed]

2011 (2)

J. Gomez-Lara, S. Brugaletta, R. Diletti, S. Garg, Y. Onuma, B. D. Gogas, R. J. van Geuns, C. Dorange, S. Veldhof, R. Rapoza, R. Whitbourn, S. Windecker, H. M. Garcia-Garcia, E. Regar, and P. W. Serruys, “A comparative assessment by optical coherence tomography of the performance of the first and second generation of the everolimus-eluting bioresorbable vascular scaffolds,” Eur. Heart J. 32(3), 294–304 (2011).
[Crossref] [PubMed]

C. Xu, J. M. Schmitt, T. Akasaka, T. Kubo, and K. Huang, “Automatic detection of stent struts with thick neointimal growth in intravascular optical coherence tomography image sequences,” Phys. Med. Biol. 56(20), 6665–6675 (2011).
[Crossref] [PubMed]

2010 (2)

P. W. Serruys, Y. Onuma, J. A. Ormiston, B. de Bruyne, E. Regar, D. Dudek, L. Thuesen, P. C. Smits, B. Chevalier, D. McClean, J. Koolen, S. Windecker, R. Whitbourn, I. Meredith, C. Dorange, S. Veldhof, K. Miquel-Hebert, R. Rapoza, and H. M. García-García, “Evaluation of the second generation of a bioresorbable everolimus drug-eluting vascular scaffold for treatment of de novo coronary artery stenosis: six-month clinical and imaging outcomes,” Circulation 122(22), 2301–2312 (2010).
[Crossref] [PubMed]

G. Unal, S. Gurmeric, and S. G. Carlier, “Stent implant follow-up in intravascular optical coherence tomography images,” Int. J. Cardiovasc. Imaging 26(7), 809–816 (2010).
[Crossref] [PubMed]

2009 (3)

S. Gurmeric, G. G. Isguder, S. Carlier, and G. Unal, “A new 3-D automated computational method to evaluate in-stent neointimal hyperplasia in in-vivo intravascular optical coherence tomography pullbacks,” Med. Image Comput. Comput. Assist. Interv. 12(Pt 2), 776–785 (2009).
[PubMed]

N. Gonzalo, P. W. Serruys, N. Piazza, and E. Regar, “Optical coherence tomography (OCT) in secondary revascularisation: stent and graft assessment,” EuroIntervention 5(Suppl D), D93–D100 (2009).
[PubMed]

P. W. Serruys, J. A. Ormiston, Y. Onuma, E. Regar, N. Gonzalo, H. M. Garcia-Garcia, K. Nieman, N. Bruining, C. Dorange, K. Miquel-Hébert, S. Veldhof, M. Webster, L. Thuesen, and D. Dudek, “A bioabsorbable everolimus-eluting coronary stent system (ABSORB): 2-year outcomes and results from multiple imaging methods,” Lancet 373(9667), 897–910 (2009).
[Crossref] [PubMed]

2008 (1)

G. Unal, S. Bucher, S. Carlier, G. Slabaugh, T. Fang, and K. Tanaka, “Shape-driven segmentation of the arterial wall in intravascular ultrasound images,” IEEE Trans. Inf. Technol. Biomed. 12(3), 335–347 (2008).
[Crossref] [PubMed]

2005 (1)

P. W. Serruys, A. T. Ong, J. J. Piek, F. J. Neumann, W. J. van der Giessen, M. Wiemer, A. Zeiher, E. Grube, J. Haase, L. Thuesen, C. Hamm, and P. C. Otto-Terlouw, “A randomized comparison of a durable polymer Everolimus-eluting stent with a bare metal coronary stent: The SPIRIT first trial,” EuroIntervention 1(1), 58–65 (2005).
[PubMed]

2003 (1)

J. E. Sousa, P. W. Serruys, and M. A. Costa, “New frontiers in cardiology: drug-eluting stents: Part I,” Circulation 107(17), 2274–2279 (2003).
[Crossref] [PubMed]

1978 (1)

A. Grüntzig, “Transluminal dilatation of coronary-artery stenosis,” Lancet 311(8058), 263 (1978).
[Crossref] [PubMed]

1959 (1)

E. W. Dijkstra, “A note on two problems in connexion with graphs,” Numer. Math. 1(1), 269–271 (1959).
[Crossref]

Akasaka, T.

C. Xu, J. M. Schmitt, T. Akasaka, T. Kubo, and K. Huang, “Automatic detection of stent struts with thick neointimal growth in intravascular optical coherence tomography image sequences,” Phys. Med. Biol. 56(20), 6665–6675 (2011).
[Crossref] [PubMed]

Brugaletta, S.

S. Brugaletta, H. M. Garcia-Garcia, Y. Onuma, and P. W. Serruys, “Everolimus-eluting ABSORB bioresorbable vascular scaffold: present and future perspectives,” Expert Rev. Med. Devices 9(4), 327–338 (2012).
[Crossref] [PubMed]

J. Gomez-Lara, S. Brugaletta, R. Diletti, S. Garg, Y. Onuma, B. D. Gogas, R. J. van Geuns, C. Dorange, S. Veldhof, R. Rapoza, R. Whitbourn, S. Windecker, H. M. Garcia-Garcia, E. Regar, and P. W. Serruys, “A comparative assessment by optical coherence tomography of the performance of the first and second generation of the everolimus-eluting bioresorbable vascular scaffolds,” Eur. Heart J. 32(3), 294–304 (2011).
[Crossref] [PubMed]

Bruining, N.

P. W. Serruys, J. A. Ormiston, Y. Onuma, E. Regar, N. Gonzalo, H. M. Garcia-Garcia, K. Nieman, N. Bruining, C. Dorange, K. Miquel-Hébert, S. Veldhof, M. Webster, L. Thuesen, and D. Dudek, “A bioabsorbable everolimus-eluting coronary stent system (ABSORB): 2-year outcomes and results from multiple imaging methods,” Lancet 373(9667), 897–910 (2009).
[Crossref] [PubMed]

Bucher, S.

G. Unal, S. Bucher, S. Carlier, G. Slabaugh, T. Fang, and K. Tanaka, “Shape-driven segmentation of the arterial wall in intravascular ultrasound images,” IEEE Trans. Inf. Technol. Biomed. 12(3), 335–347 (2008).
[Crossref] [PubMed]

Carlier, S.

S. Gurmeric, G. G. Isguder, S. Carlier, and G. Unal, “A new 3-D automated computational method to evaluate in-stent neointimal hyperplasia in in-vivo intravascular optical coherence tomography pullbacks,” Med. Image Comput. Comput. Assist. Interv. 12(Pt 2), 776–785 (2009).
[PubMed]

G. Unal, S. Bucher, S. Carlier, G. Slabaugh, T. Fang, and K. Tanaka, “Shape-driven segmentation of the arterial wall in intravascular ultrasound images,” IEEE Trans. Inf. Technol. Biomed. 12(3), 335–347 (2008).
[Crossref] [PubMed]

Carlier, S. G.

G. Unal, S. Gurmeric, and S. G. Carlier, “Stent implant follow-up in intravascular optical coherence tomography images,” Int. J. Cardiovasc. Imaging 26(7), 809–816 (2010).
[Crossref] [PubMed]

Chevalier, B.

P. W. Serruys, Y. Onuma, J. A. Ormiston, B. de Bruyne, E. Regar, D. Dudek, L. Thuesen, P. C. Smits, B. Chevalier, D. McClean, J. Koolen, S. Windecker, R. Whitbourn, I. Meredith, C. Dorange, S. Veldhof, K. Miquel-Hebert, R. Rapoza, and H. M. García-García, “Evaluation of the second generation of a bioresorbable everolimus drug-eluting vascular scaffold for treatment of de novo coronary artery stenosis: six-month clinical and imaging outcomes,” Circulation 122(22), 2301–2312 (2010).
[Crossref] [PubMed]

Costa, M. A.

J. E. Sousa, P. W. Serruys, and M. A. Costa, “New frontiers in cardiology: drug-eluting stents: Part I,” Circulation 107(17), 2274–2279 (2003).
[Crossref] [PubMed]

da Costa, B. R.

B. Kalesan, T. Pilgrim, K. Heinimann, L. Räber, G. G. Stefanini, M. Valgimigli, B. R. da Costa, F. Mach, T. F. Lüscher, B. Meier, S. Windecker, and P. Jüni, “Comparison of drug-eluting stents with bare metal stents in patients with ST-segment elevation myocardial infarction,” Eur. Heart J. 33(8), 977–987 (2012).
[Crossref] [PubMed]

de Bruyne, B.

P. W. Serruys, Y. Onuma, J. A. Ormiston, B. de Bruyne, E. Regar, D. Dudek, L. Thuesen, P. C. Smits, B. Chevalier, D. McClean, J. Koolen, S. Windecker, R. Whitbourn, I. Meredith, C. Dorange, S. Veldhof, K. Miquel-Hebert, R. Rapoza, and H. M. García-García, “Evaluation of the second generation of a bioresorbable everolimus drug-eluting vascular scaffold for treatment of de novo coronary artery stenosis: six-month clinical and imaging outcomes,” Circulation 122(22), 2301–2312 (2010).
[Crossref] [PubMed]

de Koning, P. J.

A. Wang, J. Eggermont, N. Dekker, P. J. de Koning, J. H. Reiber, and J. Dijkstra, “3D assessment of stent cell size and side branch access in intravascular optical coherence tomographic pullback runs,” Comput. Med. Imaging Graph. 38(2), 113–122 (2014).
[Crossref] [PubMed]

Dekker, N.

A. Wang, J. Eggermont, N. Dekker, P. J. de Koning, J. H. Reiber, and J. Dijkstra, “3D assessment of stent cell size and side branch access in intravascular optical coherence tomographic pullback runs,” Comput. Med. Imaging Graph. 38(2), 113–122 (2014).
[Crossref] [PubMed]

A. Wang, J. Eggermont, N. Dekker, H. M. Garcia-Garcia, R. Pawar, J. H. Reiber, and J. Dijkstra, “Automatic stent strut detection in intravascular optical coherence tomographic pullback runs,” Int. J. Cardiovasc. Imaging 29(1), 29–38 (2013).
[Crossref] [PubMed]

A. Wang, J. Eggermont, N. Dekker, H. M. Garcia-Garcia, R. Pawar, J. H. C. Reiber, and J. Dijkstra, “A robust automated method to detect stent struts in 3D intravascular optical coherence tomographic image sequences,” Proc. SPIE 8315, 83150L (2012).
[Crossref]

Dijkstra, E. W.

E. W. Dijkstra, “A note on two problems in connexion with graphs,” Numer. Math. 1(1), 269–271 (1959).
[Crossref]

Dijkstra, J.

A. Wang, J. Eggermont, N. Dekker, P. J. de Koning, J. H. Reiber, and J. Dijkstra, “3D assessment of stent cell size and side branch access in intravascular optical coherence tomographic pullback runs,” Comput. Med. Imaging Graph. 38(2), 113–122 (2014).
[Crossref] [PubMed]

A. Wang, J. Eggermont, N. Dekker, H. M. Garcia-Garcia, R. Pawar, J. H. Reiber, and J. Dijkstra, “Automatic stent strut detection in intravascular optical coherence tomographic pullback runs,” Int. J. Cardiovasc. Imaging 29(1), 29–38 (2013).
[Crossref] [PubMed]

A. Wang, J. Eggermont, N. Dekker, H. M. Garcia-Garcia, R. Pawar, J. H. C. Reiber, and J. Dijkstra, “A robust automated method to detect stent struts in 3D intravascular optical coherence tomographic image sequences,” Proc. SPIE 8315, 83150L (2012).
[Crossref]

Diletti, R.

A. Sheehy, J. L. Gutiérrez-Chico, R. Diletti, J. P. Oberhauser, T. Glauser, J. Harrington, M. B. Kossuth, R. J. Rapoza, Y. Onuma, and P. W. Serruys, “In vivo characterisation of bioresorbable vascular scaffold strut interfaces using optical coherence tomography with Gaussian line spread function analysis,” EuroIntervention 7(10), 1227–1235 (2012).
[Crossref] [PubMed]

J. L. Gutiérrez-Chico, M. D. Radu, R. Diletti, A. Sheehy, M. B. Kossuth, J. P. Oberhauser, T. Glauser, J. Harrington, R. J. Rapoza, Y. Onuma, and P. W. Serruys, “Spatial distribution and temporal evolution of scattering centers by optical coherence tomography in the poly(L-lactide) backbone of a bioresorbable vascular scaffold,” Circ. J. 76(2), 342–350 (2012).
[Crossref] [PubMed]

J. Gomez-Lara, S. Brugaletta, R. Diletti, S. Garg, Y. Onuma, B. D. Gogas, R. J. van Geuns, C. Dorange, S. Veldhof, R. Rapoza, R. Whitbourn, S. Windecker, H. M. Garcia-Garcia, E. Regar, and P. W. Serruys, “A comparative assessment by optical coherence tomography of the performance of the first and second generation of the everolimus-eluting bioresorbable vascular scaffolds,” Eur. Heart J. 32(3), 294–304 (2011).
[Crossref] [PubMed]

Dorange, C.

J. Gomez-Lara, S. Brugaletta, R. Diletti, S. Garg, Y. Onuma, B. D. Gogas, R. J. van Geuns, C. Dorange, S. Veldhof, R. Rapoza, R. Whitbourn, S. Windecker, H. M. Garcia-Garcia, E. Regar, and P. W. Serruys, “A comparative assessment by optical coherence tomography of the performance of the first and second generation of the everolimus-eluting bioresorbable vascular scaffolds,” Eur. Heart J. 32(3), 294–304 (2011).
[Crossref] [PubMed]

P. W. Serruys, Y. Onuma, J. A. Ormiston, B. de Bruyne, E. Regar, D. Dudek, L. Thuesen, P. C. Smits, B. Chevalier, D. McClean, J. Koolen, S. Windecker, R. Whitbourn, I. Meredith, C. Dorange, S. Veldhof, K. Miquel-Hebert, R. Rapoza, and H. M. García-García, “Evaluation of the second generation of a bioresorbable everolimus drug-eluting vascular scaffold for treatment of de novo coronary artery stenosis: six-month clinical and imaging outcomes,” Circulation 122(22), 2301–2312 (2010).
[Crossref] [PubMed]

P. W. Serruys, J. A. Ormiston, Y. Onuma, E. Regar, N. Gonzalo, H. M. Garcia-Garcia, K. Nieman, N. Bruining, C. Dorange, K. Miquel-Hébert, S. Veldhof, M. Webster, L. Thuesen, and D. Dudek, “A bioabsorbable everolimus-eluting coronary stent system (ABSORB): 2-year outcomes and results from multiple imaging methods,” Lancet 373(9667), 897–910 (2009).
[Crossref] [PubMed]

Dudek, D.

D. Dudek, Y. Onuma, J. A. Ormiston, L. Thuesen, K. Miquel-Hebert, and P. W. Serruys, “Four-year clinical follow-up of the ABSORB everolimus-eluting bioresorbable vascular scaffold in patients with de novo coronary artery disease: the ABSORB trial,” EuroIntervention 7(9), 1060–1061 (2012).
[Crossref] [PubMed]

P. W. Serruys, Y. Onuma, J. A. Ormiston, B. de Bruyne, E. Regar, D. Dudek, L. Thuesen, P. C. Smits, B. Chevalier, D. McClean, J. Koolen, S. Windecker, R. Whitbourn, I. Meredith, C. Dorange, S. Veldhof, K. Miquel-Hebert, R. Rapoza, and H. M. García-García, “Evaluation of the second generation of a bioresorbable everolimus drug-eluting vascular scaffold for treatment of de novo coronary artery stenosis: six-month clinical and imaging outcomes,” Circulation 122(22), 2301–2312 (2010).
[Crossref] [PubMed]

P. W. Serruys, J. A. Ormiston, Y. Onuma, E. Regar, N. Gonzalo, H. M. Garcia-Garcia, K. Nieman, N. Bruining, C. Dorange, K. Miquel-Hébert, S. Veldhof, M. Webster, L. Thuesen, and D. Dudek, “A bioabsorbable everolimus-eluting coronary stent system (ABSORB): 2-year outcomes and results from multiple imaging methods,” Lancet 373(9667), 897–910 (2009).
[Crossref] [PubMed]

Eggermont, J.

A. Wang, J. Eggermont, N. Dekker, P. J. de Koning, J. H. Reiber, and J. Dijkstra, “3D assessment of stent cell size and side branch access in intravascular optical coherence tomographic pullback runs,” Comput. Med. Imaging Graph. 38(2), 113–122 (2014).
[Crossref] [PubMed]

A. Wang, J. Eggermont, N. Dekker, H. M. Garcia-Garcia, R. Pawar, J. H. Reiber, and J. Dijkstra, “Automatic stent strut detection in intravascular optical coherence tomographic pullback runs,” Int. J. Cardiovasc. Imaging 29(1), 29–38 (2013).
[Crossref] [PubMed]

A. Wang, J. Eggermont, N. Dekker, H. M. Garcia-Garcia, R. Pawar, J. H. C. Reiber, and J. Dijkstra, “A robust automated method to detect stent struts in 3D intravascular optical coherence tomographic image sequences,” Proc. SPIE 8315, 83150L (2012).
[Crossref]

Fang, T.

G. Unal, S. Bucher, S. Carlier, G. Slabaugh, T. Fang, and K. Tanaka, “Shape-driven segmentation of the arterial wall in intravascular ultrasound images,” IEEE Trans. Inf. Technol. Biomed. 12(3), 335–347 (2008).
[Crossref] [PubMed]

Farooq, V.

B. D. Gogas, V. Farooq, Y. Onuma, and P. W. Serruys, “The ABSORB bioresorbable vascular scaffold: an evolution or revolution in interventional cardiology?” Hellenic J. Cardiol. 53(4), 301–309 (2012).
[PubMed]

Garcia-Garcia, H. M.

A. Wang, J. Eggermont, N. Dekker, H. M. Garcia-Garcia, R. Pawar, J. H. Reiber, and J. Dijkstra, “Automatic stent strut detection in intravascular optical coherence tomographic pullback runs,” Int. J. Cardiovasc. Imaging 29(1), 29–38 (2013).
[Crossref] [PubMed]

A. Wang, J. Eggermont, N. Dekker, H. M. Garcia-Garcia, R. Pawar, J. H. C. Reiber, and J. Dijkstra, “A robust automated method to detect stent struts in 3D intravascular optical coherence tomographic image sequences,” Proc. SPIE 8315, 83150L (2012).
[Crossref]

S. Brugaletta, H. M. Garcia-Garcia, Y. Onuma, and P. W. Serruys, “Everolimus-eluting ABSORB bioresorbable vascular scaffold: present and future perspectives,” Expert Rev. Med. Devices 9(4), 327–338 (2012).
[Crossref] [PubMed]

J. Gomez-Lara, S. Brugaletta, R. Diletti, S. Garg, Y. Onuma, B. D. Gogas, R. J. van Geuns, C. Dorange, S. Veldhof, R. Rapoza, R. Whitbourn, S. Windecker, H. M. Garcia-Garcia, E. Regar, and P. W. Serruys, “A comparative assessment by optical coherence tomography of the performance of the first and second generation of the everolimus-eluting bioresorbable vascular scaffolds,” Eur. Heart J. 32(3), 294–304 (2011).
[Crossref] [PubMed]

P. W. Serruys, J. A. Ormiston, Y. Onuma, E. Regar, N. Gonzalo, H. M. Garcia-Garcia, K. Nieman, N. Bruining, C. Dorange, K. Miquel-Hébert, S. Veldhof, M. Webster, L. Thuesen, and D. Dudek, “A bioabsorbable everolimus-eluting coronary stent system (ABSORB): 2-year outcomes and results from multiple imaging methods,” Lancet 373(9667), 897–910 (2009).
[Crossref] [PubMed]

García-García, H. M.

P. W. Serruys, Y. Onuma, J. A. Ormiston, B. de Bruyne, E. Regar, D. Dudek, L. Thuesen, P. C. Smits, B. Chevalier, D. McClean, J. Koolen, S. Windecker, R. Whitbourn, I. Meredith, C. Dorange, S. Veldhof, K. Miquel-Hebert, R. Rapoza, and H. M. García-García, “Evaluation of the second generation of a bioresorbable everolimus drug-eluting vascular scaffold for treatment of de novo coronary artery stenosis: six-month clinical and imaging outcomes,” Circulation 122(22), 2301–2312 (2010).
[Crossref] [PubMed]

Garg, S.

J. Gomez-Lara, S. Brugaletta, R. Diletti, S. Garg, Y. Onuma, B. D. Gogas, R. J. van Geuns, C. Dorange, S. Veldhof, R. Rapoza, R. Whitbourn, S. Windecker, H. M. Garcia-Garcia, E. Regar, and P. W. Serruys, “A comparative assessment by optical coherence tomography of the performance of the first and second generation of the everolimus-eluting bioresorbable vascular scaffolds,” Eur. Heart J. 32(3), 294–304 (2011).
[Crossref] [PubMed]

Glauser, T.

A. Sheehy, J. L. Gutiérrez-Chico, R. Diletti, J. P. Oberhauser, T. Glauser, J. Harrington, M. B. Kossuth, R. J. Rapoza, Y. Onuma, and P. W. Serruys, “In vivo characterisation of bioresorbable vascular scaffold strut interfaces using optical coherence tomography with Gaussian line spread function analysis,” EuroIntervention 7(10), 1227–1235 (2012).
[Crossref] [PubMed]

J. L. Gutiérrez-Chico, M. D. Radu, R. Diletti, A. Sheehy, M. B. Kossuth, J. P. Oberhauser, T. Glauser, J. Harrington, R. J. Rapoza, Y. Onuma, and P. W. Serruys, “Spatial distribution and temporal evolution of scattering centers by optical coherence tomography in the poly(L-lactide) backbone of a bioresorbable vascular scaffold,” Circ. J. 76(2), 342–350 (2012).
[Crossref] [PubMed]

Gogas, B. D.

B. D. Gogas, V. Farooq, Y. Onuma, and P. W. Serruys, “The ABSORB bioresorbable vascular scaffold: an evolution or revolution in interventional cardiology?” Hellenic J. Cardiol. 53(4), 301–309 (2012).
[PubMed]

J. Gomez-Lara, S. Brugaletta, R. Diletti, S. Garg, Y. Onuma, B. D. Gogas, R. J. van Geuns, C. Dorange, S. Veldhof, R. Rapoza, R. Whitbourn, S. Windecker, H. M. Garcia-Garcia, E. Regar, and P. W. Serruys, “A comparative assessment by optical coherence tomography of the performance of the first and second generation of the everolimus-eluting bioresorbable vascular scaffolds,” Eur. Heart J. 32(3), 294–304 (2011).
[Crossref] [PubMed]

Gomez-Lara, J.

J. Gomez-Lara, S. Brugaletta, R. Diletti, S. Garg, Y. Onuma, B. D. Gogas, R. J. van Geuns, C. Dorange, S. Veldhof, R. Rapoza, R. Whitbourn, S. Windecker, H. M. Garcia-Garcia, E. Regar, and P. W. Serruys, “A comparative assessment by optical coherence tomography of the performance of the first and second generation of the everolimus-eluting bioresorbable vascular scaffolds,” Eur. Heart J. 32(3), 294–304 (2011).
[Crossref] [PubMed]

Gonzalo, N.

P. W. Serruys, J. A. Ormiston, Y. Onuma, E. Regar, N. Gonzalo, H. M. Garcia-Garcia, K. Nieman, N. Bruining, C. Dorange, K. Miquel-Hébert, S. Veldhof, M. Webster, L. Thuesen, and D. Dudek, “A bioabsorbable everolimus-eluting coronary stent system (ABSORB): 2-year outcomes and results from multiple imaging methods,” Lancet 373(9667), 897–910 (2009).
[Crossref] [PubMed]

N. Gonzalo, P. W. Serruys, N. Piazza, and E. Regar, “Optical coherence tomography (OCT) in secondary revascularisation: stent and graft assessment,” EuroIntervention 5(Suppl D), D93–D100 (2009).
[PubMed]

Grube, E.

P. W. Serruys, A. T. Ong, J. J. Piek, F. J. Neumann, W. J. van der Giessen, M. Wiemer, A. Zeiher, E. Grube, J. Haase, L. Thuesen, C. Hamm, and P. C. Otto-Terlouw, “A randomized comparison of a durable polymer Everolimus-eluting stent with a bare metal coronary stent: The SPIRIT first trial,” EuroIntervention 1(1), 58–65 (2005).
[PubMed]

Grüntzig, A.

A. Grüntzig, “Transluminal dilatation of coronary-artery stenosis,” Lancet 311(8058), 263 (1978).
[Crossref] [PubMed]

Gurmeric, S.

G. Unal, S. Gurmeric, and S. G. Carlier, “Stent implant follow-up in intravascular optical coherence tomography images,” Int. J. Cardiovasc. Imaging 26(7), 809–816 (2010).
[Crossref] [PubMed]

S. Gurmeric, G. G. Isguder, S. Carlier, and G. Unal, “A new 3-D automated computational method to evaluate in-stent neointimal hyperplasia in in-vivo intravascular optical coherence tomography pullbacks,” Med. Image Comput. Comput. Assist. Interv. 12(Pt 2), 776–785 (2009).
[PubMed]

Gutiérrez-Chico, J. L.

A. Sheehy, J. L. Gutiérrez-Chico, R. Diletti, J. P. Oberhauser, T. Glauser, J. Harrington, M. B. Kossuth, R. J. Rapoza, Y. Onuma, and P. W. Serruys, “In vivo characterisation of bioresorbable vascular scaffold strut interfaces using optical coherence tomography with Gaussian line spread function analysis,” EuroIntervention 7(10), 1227–1235 (2012).
[Crossref] [PubMed]

J. L. Gutiérrez-Chico, M. D. Radu, R. Diletti, A. Sheehy, M. B. Kossuth, J. P. Oberhauser, T. Glauser, J. Harrington, R. J. Rapoza, Y. Onuma, and P. W. Serruys, “Spatial distribution and temporal evolution of scattering centers by optical coherence tomography in the poly(L-lactide) backbone of a bioresorbable vascular scaffold,” Circ. J. 76(2), 342–350 (2012).
[Crossref] [PubMed]

Haase, J.

P. W. Serruys, A. T. Ong, J. J. Piek, F. J. Neumann, W. J. van der Giessen, M. Wiemer, A. Zeiher, E. Grube, J. Haase, L. Thuesen, C. Hamm, and P. C. Otto-Terlouw, “A randomized comparison of a durable polymer Everolimus-eluting stent with a bare metal coronary stent: The SPIRIT first trial,” EuroIntervention 1(1), 58–65 (2005).
[PubMed]

Hamm, C.

P. W. Serruys, A. T. Ong, J. J. Piek, F. J. Neumann, W. J. van der Giessen, M. Wiemer, A. Zeiher, E. Grube, J. Haase, L. Thuesen, C. Hamm, and P. C. Otto-Terlouw, “A randomized comparison of a durable polymer Everolimus-eluting stent with a bare metal coronary stent: The SPIRIT first trial,” EuroIntervention 1(1), 58–65 (2005).
[PubMed]

Harrington, J.

J. L. Gutiérrez-Chico, M. D. Radu, R. Diletti, A. Sheehy, M. B. Kossuth, J. P. Oberhauser, T. Glauser, J. Harrington, R. J. Rapoza, Y. Onuma, and P. W. Serruys, “Spatial distribution and temporal evolution of scattering centers by optical coherence tomography in the poly(L-lactide) backbone of a bioresorbable vascular scaffold,” Circ. J. 76(2), 342–350 (2012).
[Crossref] [PubMed]

A. Sheehy, J. L. Gutiérrez-Chico, R. Diletti, J. P. Oberhauser, T. Glauser, J. Harrington, M. B. Kossuth, R. J. Rapoza, Y. Onuma, and P. W. Serruys, “In vivo characterisation of bioresorbable vascular scaffold strut interfaces using optical coherence tomography with Gaussian line spread function analysis,” EuroIntervention 7(10), 1227–1235 (2012).
[Crossref] [PubMed]

Heinimann, K.

B. Kalesan, T. Pilgrim, K. Heinimann, L. Räber, G. G. Stefanini, M. Valgimigli, B. R. da Costa, F. Mach, T. F. Lüscher, B. Meier, S. Windecker, and P. Jüni, “Comparison of drug-eluting stents with bare metal stents in patients with ST-segment elevation myocardial infarction,” Eur. Heart J. 33(8), 977–987 (2012).
[Crossref] [PubMed]

Huang, K.

C. Xu, J. M. Schmitt, T. Akasaka, T. Kubo, and K. Huang, “Automatic detection of stent struts with thick neointimal growth in intravascular optical coherence tomography image sequences,” Phys. Med. Biol. 56(20), 6665–6675 (2011).
[Crossref] [PubMed]

Isguder, G. G.

S. Gurmeric, G. G. Isguder, S. Carlier, and G. Unal, “A new 3-D automated computational method to evaluate in-stent neointimal hyperplasia in in-vivo intravascular optical coherence tomography pullbacks,” Med. Image Comput. Comput. Assist. Interv. 12(Pt 2), 776–785 (2009).
[PubMed]

Jüni, P.

B. Kalesan, T. Pilgrim, K. Heinimann, L. Räber, G. G. Stefanini, M. Valgimigli, B. R. da Costa, F. Mach, T. F. Lüscher, B. Meier, S. Windecker, and P. Jüni, “Comparison of drug-eluting stents with bare metal stents in patients with ST-segment elevation myocardial infarction,” Eur. Heart J. 33(8), 977–987 (2012).
[Crossref] [PubMed]

Kalesan, B.

B. Kalesan, T. Pilgrim, K. Heinimann, L. Räber, G. G. Stefanini, M. Valgimigli, B. R. da Costa, F. Mach, T. F. Lüscher, B. Meier, S. Windecker, and P. Jüni, “Comparison of drug-eluting stents with bare metal stents in patients with ST-segment elevation myocardial infarction,” Eur. Heart J. 33(8), 977–987 (2012).
[Crossref] [PubMed]

Karanasos, A.

A. Karanasos, C. Simsek, P. Serruys, J. Ligthart, K. Witberg, R. J. van Geuns, G. Sianos, F. Zijlstra, and E. Regar, “Five-year optical coherence tomography follow-up of an everolimus-eluting bioresorbable vascular scaffold: changing the paradigm of coronary stenting?” Circulation 126(7), e89–e91 (2012).
[Crossref] [PubMed]

Koolen, J.

P. W. Serruys, Y. Onuma, J. A. Ormiston, B. de Bruyne, E. Regar, D. Dudek, L. Thuesen, P. C. Smits, B. Chevalier, D. McClean, J. Koolen, S. Windecker, R. Whitbourn, I. Meredith, C. Dorange, S. Veldhof, K. Miquel-Hebert, R. Rapoza, and H. M. García-García, “Evaluation of the second generation of a bioresorbable everolimus drug-eluting vascular scaffold for treatment of de novo coronary artery stenosis: six-month clinical and imaging outcomes,” Circulation 122(22), 2301–2312 (2010).
[Crossref] [PubMed]

Kossuth, M. B.

A. Sheehy, J. L. Gutiérrez-Chico, R. Diletti, J. P. Oberhauser, T. Glauser, J. Harrington, M. B. Kossuth, R. J. Rapoza, Y. Onuma, and P. W. Serruys, “In vivo characterisation of bioresorbable vascular scaffold strut interfaces using optical coherence tomography with Gaussian line spread function analysis,” EuroIntervention 7(10), 1227–1235 (2012).
[Crossref] [PubMed]

J. L. Gutiérrez-Chico, M. D. Radu, R. Diletti, A. Sheehy, M. B. Kossuth, J. P. Oberhauser, T. Glauser, J. Harrington, R. J. Rapoza, Y. Onuma, and P. W. Serruys, “Spatial distribution and temporal evolution of scattering centers by optical coherence tomography in the poly(L-lactide) backbone of a bioresorbable vascular scaffold,” Circ. J. 76(2), 342–350 (2012).
[Crossref] [PubMed]

Kubo, T.

C. Xu, J. M. Schmitt, T. Akasaka, T. Kubo, and K. Huang, “Automatic detection of stent struts with thick neointimal growth in intravascular optical coherence tomography image sequences,” Phys. Med. Biol. 56(20), 6665–6675 (2011).
[Crossref] [PubMed]

Ligthart, J.

A. Karanasos, C. Simsek, P. Serruys, J. Ligthart, K. Witberg, R. J. van Geuns, G. Sianos, F. Zijlstra, and E. Regar, “Five-year optical coherence tomography follow-up of an everolimus-eluting bioresorbable vascular scaffold: changing the paradigm of coronary stenting?” Circulation 126(7), e89–e91 (2012).
[Crossref] [PubMed]

Lüscher, T. F.

B. Kalesan, T. Pilgrim, K. Heinimann, L. Räber, G. G. Stefanini, M. Valgimigli, B. R. da Costa, F. Mach, T. F. Lüscher, B. Meier, S. Windecker, and P. Jüni, “Comparison of drug-eluting stents with bare metal stents in patients with ST-segment elevation myocardial infarction,” Eur. Heart J. 33(8), 977–987 (2012).
[Crossref] [PubMed]

Mach, F.

B. Kalesan, T. Pilgrim, K. Heinimann, L. Räber, G. G. Stefanini, M. Valgimigli, B. R. da Costa, F. Mach, T. F. Lüscher, B. Meier, S. Windecker, and P. Jüni, “Comparison of drug-eluting stents with bare metal stents in patients with ST-segment elevation myocardial infarction,” Eur. Heart J. 33(8), 977–987 (2012).
[Crossref] [PubMed]

McClean, D.

P. W. Serruys, Y. Onuma, J. A. Ormiston, B. de Bruyne, E. Regar, D. Dudek, L. Thuesen, P. C. Smits, B. Chevalier, D. McClean, J. Koolen, S. Windecker, R. Whitbourn, I. Meredith, C. Dorange, S. Veldhof, K. Miquel-Hebert, R. Rapoza, and H. M. García-García, “Evaluation of the second generation of a bioresorbable everolimus drug-eluting vascular scaffold for treatment of de novo coronary artery stenosis: six-month clinical and imaging outcomes,” Circulation 122(22), 2301–2312 (2010).
[Crossref] [PubMed]

Meier, B.

B. Kalesan, T. Pilgrim, K. Heinimann, L. Räber, G. G. Stefanini, M. Valgimigli, B. R. da Costa, F. Mach, T. F. Lüscher, B. Meier, S. Windecker, and P. Jüni, “Comparison of drug-eluting stents with bare metal stents in patients with ST-segment elevation myocardial infarction,” Eur. Heart J. 33(8), 977–987 (2012).
[Crossref] [PubMed]

Meredith, I.

P. W. Serruys, Y. Onuma, J. A. Ormiston, B. de Bruyne, E. Regar, D. Dudek, L. Thuesen, P. C. Smits, B. Chevalier, D. McClean, J. Koolen, S. Windecker, R. Whitbourn, I. Meredith, C. Dorange, S. Veldhof, K. Miquel-Hebert, R. Rapoza, and H. M. García-García, “Evaluation of the second generation of a bioresorbable everolimus drug-eluting vascular scaffold for treatment of de novo coronary artery stenosis: six-month clinical and imaging outcomes,” Circulation 122(22), 2301–2312 (2010).
[Crossref] [PubMed]

Miquel-Hebert, K.

D. Dudek, Y. Onuma, J. A. Ormiston, L. Thuesen, K. Miquel-Hebert, and P. W. Serruys, “Four-year clinical follow-up of the ABSORB everolimus-eluting bioresorbable vascular scaffold in patients with de novo coronary artery disease: the ABSORB trial,” EuroIntervention 7(9), 1060–1061 (2012).
[Crossref] [PubMed]

P. W. Serruys, Y. Onuma, J. A. Ormiston, B. de Bruyne, E. Regar, D. Dudek, L. Thuesen, P. C. Smits, B. Chevalier, D. McClean, J. Koolen, S. Windecker, R. Whitbourn, I. Meredith, C. Dorange, S. Veldhof, K. Miquel-Hebert, R. Rapoza, and H. M. García-García, “Evaluation of the second generation of a bioresorbable everolimus drug-eluting vascular scaffold for treatment of de novo coronary artery stenosis: six-month clinical and imaging outcomes,” Circulation 122(22), 2301–2312 (2010).
[Crossref] [PubMed]

Miquel-Hébert, K.

P. W. Serruys, J. A. Ormiston, Y. Onuma, E. Regar, N. Gonzalo, H. M. Garcia-Garcia, K. Nieman, N. Bruining, C. Dorange, K. Miquel-Hébert, S. Veldhof, M. Webster, L. Thuesen, and D. Dudek, “A bioabsorbable everolimus-eluting coronary stent system (ABSORB): 2-year outcomes and results from multiple imaging methods,” Lancet 373(9667), 897–910 (2009).
[Crossref] [PubMed]

Neumann, F. J.

P. W. Serruys, A. T. Ong, J. J. Piek, F. J. Neumann, W. J. van der Giessen, M. Wiemer, A. Zeiher, E. Grube, J. Haase, L. Thuesen, C. Hamm, and P. C. Otto-Terlouw, “A randomized comparison of a durable polymer Everolimus-eluting stent with a bare metal coronary stent: The SPIRIT first trial,” EuroIntervention 1(1), 58–65 (2005).
[PubMed]

Nieman, K.

P. W. Serruys, J. A. Ormiston, Y. Onuma, E. Regar, N. Gonzalo, H. M. Garcia-Garcia, K. Nieman, N. Bruining, C. Dorange, K. Miquel-Hébert, S. Veldhof, M. Webster, L. Thuesen, and D. Dudek, “A bioabsorbable everolimus-eluting coronary stent system (ABSORB): 2-year outcomes and results from multiple imaging methods,” Lancet 373(9667), 897–910 (2009).
[Crossref] [PubMed]

Oberhauser, J. P.

A. Sheehy, J. L. Gutiérrez-Chico, R. Diletti, J. P. Oberhauser, T. Glauser, J. Harrington, M. B. Kossuth, R. J. Rapoza, Y. Onuma, and P. W. Serruys, “In vivo characterisation of bioresorbable vascular scaffold strut interfaces using optical coherence tomography with Gaussian line spread function analysis,” EuroIntervention 7(10), 1227–1235 (2012).
[Crossref] [PubMed]

J. L. Gutiérrez-Chico, M. D. Radu, R. Diletti, A. Sheehy, M. B. Kossuth, J. P. Oberhauser, T. Glauser, J. Harrington, R. J. Rapoza, Y. Onuma, and P. W. Serruys, “Spatial distribution and temporal evolution of scattering centers by optical coherence tomography in the poly(L-lactide) backbone of a bioresorbable vascular scaffold,” Circ. J. 76(2), 342–350 (2012).
[Crossref] [PubMed]

Ong, A. T.

P. W. Serruys, A. T. Ong, J. J. Piek, F. J. Neumann, W. J. van der Giessen, M. Wiemer, A. Zeiher, E. Grube, J. Haase, L. Thuesen, C. Hamm, and P. C. Otto-Terlouw, “A randomized comparison of a durable polymer Everolimus-eluting stent with a bare metal coronary stent: The SPIRIT first trial,” EuroIntervention 1(1), 58–65 (2005).
[PubMed]

Onuma, Y.

S. Brugaletta, H. M. Garcia-Garcia, Y. Onuma, and P. W. Serruys, “Everolimus-eluting ABSORB bioresorbable vascular scaffold: present and future perspectives,” Expert Rev. Med. Devices 9(4), 327–338 (2012).
[Crossref] [PubMed]

D. Dudek, Y. Onuma, J. A. Ormiston, L. Thuesen, K. Miquel-Hebert, and P. W. Serruys, “Four-year clinical follow-up of the ABSORB everolimus-eluting bioresorbable vascular scaffold in patients with de novo coronary artery disease: the ABSORB trial,” EuroIntervention 7(9), 1060–1061 (2012).
[Crossref] [PubMed]

J. L. Gutiérrez-Chico, M. D. Radu, R. Diletti, A. Sheehy, M. B. Kossuth, J. P. Oberhauser, T. Glauser, J. Harrington, R. J. Rapoza, Y. Onuma, and P. W. Serruys, “Spatial distribution and temporal evolution of scattering centers by optical coherence tomography in the poly(L-lactide) backbone of a bioresorbable vascular scaffold,” Circ. J. 76(2), 342–350 (2012).
[Crossref] [PubMed]

A. Sheehy, J. L. Gutiérrez-Chico, R. Diletti, J. P. Oberhauser, T. Glauser, J. Harrington, M. B. Kossuth, R. J. Rapoza, Y. Onuma, and P. W. Serruys, “In vivo characterisation of bioresorbable vascular scaffold strut interfaces using optical coherence tomography with Gaussian line spread function analysis,” EuroIntervention 7(10), 1227–1235 (2012).
[Crossref] [PubMed]

B. D. Gogas, V. Farooq, Y. Onuma, and P. W. Serruys, “The ABSORB bioresorbable vascular scaffold: an evolution or revolution in interventional cardiology?” Hellenic J. Cardiol. 53(4), 301–309 (2012).
[PubMed]

J. Gomez-Lara, S. Brugaletta, R. Diletti, S. Garg, Y. Onuma, B. D. Gogas, R. J. van Geuns, C. Dorange, S. Veldhof, R. Rapoza, R. Whitbourn, S. Windecker, H. M. Garcia-Garcia, E. Regar, and P. W. Serruys, “A comparative assessment by optical coherence tomography of the performance of the first and second generation of the everolimus-eluting bioresorbable vascular scaffolds,” Eur. Heart J. 32(3), 294–304 (2011).
[Crossref] [PubMed]

P. W. Serruys, Y. Onuma, J. A. Ormiston, B. de Bruyne, E. Regar, D. Dudek, L. Thuesen, P. C. Smits, B. Chevalier, D. McClean, J. Koolen, S. Windecker, R. Whitbourn, I. Meredith, C. Dorange, S. Veldhof, K. Miquel-Hebert, R. Rapoza, and H. M. García-García, “Evaluation of the second generation of a bioresorbable everolimus drug-eluting vascular scaffold for treatment of de novo coronary artery stenosis: six-month clinical and imaging outcomes,” Circulation 122(22), 2301–2312 (2010).
[Crossref] [PubMed]

P. W. Serruys, J. A. Ormiston, Y. Onuma, E. Regar, N. Gonzalo, H. M. Garcia-Garcia, K. Nieman, N. Bruining, C. Dorange, K. Miquel-Hébert, S. Veldhof, M. Webster, L. Thuesen, and D. Dudek, “A bioabsorbable everolimus-eluting coronary stent system (ABSORB): 2-year outcomes and results from multiple imaging methods,” Lancet 373(9667), 897–910 (2009).
[Crossref] [PubMed]

Ormiston, J. A.

D. Dudek, Y. Onuma, J. A. Ormiston, L. Thuesen, K. Miquel-Hebert, and P. W. Serruys, “Four-year clinical follow-up of the ABSORB everolimus-eluting bioresorbable vascular scaffold in patients with de novo coronary artery disease: the ABSORB trial,” EuroIntervention 7(9), 1060–1061 (2012).
[Crossref] [PubMed]

P. W. Serruys, Y. Onuma, J. A. Ormiston, B. de Bruyne, E. Regar, D. Dudek, L. Thuesen, P. C. Smits, B. Chevalier, D. McClean, J. Koolen, S. Windecker, R. Whitbourn, I. Meredith, C. Dorange, S. Veldhof, K. Miquel-Hebert, R. Rapoza, and H. M. García-García, “Evaluation of the second generation of a bioresorbable everolimus drug-eluting vascular scaffold for treatment of de novo coronary artery stenosis: six-month clinical and imaging outcomes,” Circulation 122(22), 2301–2312 (2010).
[Crossref] [PubMed]

P. W. Serruys, J. A. Ormiston, Y. Onuma, E. Regar, N. Gonzalo, H. M. Garcia-Garcia, K. Nieman, N. Bruining, C. Dorange, K. Miquel-Hébert, S. Veldhof, M. Webster, L. Thuesen, and D. Dudek, “A bioabsorbable everolimus-eluting coronary stent system (ABSORB): 2-year outcomes and results from multiple imaging methods,” Lancet 373(9667), 897–910 (2009).
[Crossref] [PubMed]

Otto-Terlouw, P. C.

P. W. Serruys, A. T. Ong, J. J. Piek, F. J. Neumann, W. J. van der Giessen, M. Wiemer, A. Zeiher, E. Grube, J. Haase, L. Thuesen, C. Hamm, and P. C. Otto-Terlouw, “A randomized comparison of a durable polymer Everolimus-eluting stent with a bare metal coronary stent: The SPIRIT first trial,” EuroIntervention 1(1), 58–65 (2005).
[PubMed]

Pawar, R.

A. Wang, J. Eggermont, N. Dekker, H. M. Garcia-Garcia, R. Pawar, J. H. Reiber, and J. Dijkstra, “Automatic stent strut detection in intravascular optical coherence tomographic pullback runs,” Int. J. Cardiovasc. Imaging 29(1), 29–38 (2013).
[Crossref] [PubMed]

A. Wang, J. Eggermont, N. Dekker, H. M. Garcia-Garcia, R. Pawar, J. H. C. Reiber, and J. Dijkstra, “A robust automated method to detect stent struts in 3D intravascular optical coherence tomographic image sequences,” Proc. SPIE 8315, 83150L (2012).
[Crossref]

Piazza, N.

N. Gonzalo, P. W. Serruys, N. Piazza, and E. Regar, “Optical coherence tomography (OCT) in secondary revascularisation: stent and graft assessment,” EuroIntervention 5(Suppl D), D93–D100 (2009).
[PubMed]

Piek, J. J.

P. W. Serruys, A. T. Ong, J. J. Piek, F. J. Neumann, W. J. van der Giessen, M. Wiemer, A. Zeiher, E. Grube, J. Haase, L. Thuesen, C. Hamm, and P. C. Otto-Terlouw, “A randomized comparison of a durable polymer Everolimus-eluting stent with a bare metal coronary stent: The SPIRIT first trial,” EuroIntervention 1(1), 58–65 (2005).
[PubMed]

Pilgrim, T.

B. Kalesan, T. Pilgrim, K. Heinimann, L. Räber, G. G. Stefanini, M. Valgimigli, B. R. da Costa, F. Mach, T. F. Lüscher, B. Meier, S. Windecker, and P. Jüni, “Comparison of drug-eluting stents with bare metal stents in patients with ST-segment elevation myocardial infarction,” Eur. Heart J. 33(8), 977–987 (2012).
[Crossref] [PubMed]

Räber, L.

B. Kalesan, T. Pilgrim, K. Heinimann, L. Räber, G. G. Stefanini, M. Valgimigli, B. R. da Costa, F. Mach, T. F. Lüscher, B. Meier, S. Windecker, and P. Jüni, “Comparison of drug-eluting stents with bare metal stents in patients with ST-segment elevation myocardial infarction,” Eur. Heart J. 33(8), 977–987 (2012).
[Crossref] [PubMed]

Radu, M. D.

J. L. Gutiérrez-Chico, M. D. Radu, R. Diletti, A. Sheehy, M. B. Kossuth, J. P. Oberhauser, T. Glauser, J. Harrington, R. J. Rapoza, Y. Onuma, and P. W. Serruys, “Spatial distribution and temporal evolution of scattering centers by optical coherence tomography in the poly(L-lactide) backbone of a bioresorbable vascular scaffold,” Circ. J. 76(2), 342–350 (2012).
[Crossref] [PubMed]

Rapoza, R.

J. Gomez-Lara, S. Brugaletta, R. Diletti, S. Garg, Y. Onuma, B. D. Gogas, R. J. van Geuns, C. Dorange, S. Veldhof, R. Rapoza, R. Whitbourn, S. Windecker, H. M. Garcia-Garcia, E. Regar, and P. W. Serruys, “A comparative assessment by optical coherence tomography of the performance of the first and second generation of the everolimus-eluting bioresorbable vascular scaffolds,” Eur. Heart J. 32(3), 294–304 (2011).
[Crossref] [PubMed]

P. W. Serruys, Y. Onuma, J. A. Ormiston, B. de Bruyne, E. Regar, D. Dudek, L. Thuesen, P. C. Smits, B. Chevalier, D. McClean, J. Koolen, S. Windecker, R. Whitbourn, I. Meredith, C. Dorange, S. Veldhof, K. Miquel-Hebert, R. Rapoza, and H. M. García-García, “Evaluation of the second generation of a bioresorbable everolimus drug-eluting vascular scaffold for treatment of de novo coronary artery stenosis: six-month clinical and imaging outcomes,” Circulation 122(22), 2301–2312 (2010).
[Crossref] [PubMed]

Rapoza, R. J.

A. Sheehy, J. L. Gutiérrez-Chico, R. Diletti, J. P. Oberhauser, T. Glauser, J. Harrington, M. B. Kossuth, R. J. Rapoza, Y. Onuma, and P. W. Serruys, “In vivo characterisation of bioresorbable vascular scaffold strut interfaces using optical coherence tomography with Gaussian line spread function analysis,” EuroIntervention 7(10), 1227–1235 (2012).
[Crossref] [PubMed]

J. L. Gutiérrez-Chico, M. D. Radu, R. Diletti, A. Sheehy, M. B. Kossuth, J. P. Oberhauser, T. Glauser, J. Harrington, R. J. Rapoza, Y. Onuma, and P. W. Serruys, “Spatial distribution and temporal evolution of scattering centers by optical coherence tomography in the poly(L-lactide) backbone of a bioresorbable vascular scaffold,” Circ. J. 76(2), 342–350 (2012).
[Crossref] [PubMed]

Regar, E.

A. Karanasos, C. Simsek, P. Serruys, J. Ligthart, K. Witberg, R. J. van Geuns, G. Sianos, F. Zijlstra, and E. Regar, “Five-year optical coherence tomography follow-up of an everolimus-eluting bioresorbable vascular scaffold: changing the paradigm of coronary stenting?” Circulation 126(7), e89–e91 (2012).
[Crossref] [PubMed]

J. Gomez-Lara, S. Brugaletta, R. Diletti, S. Garg, Y. Onuma, B. D. Gogas, R. J. van Geuns, C. Dorange, S. Veldhof, R. Rapoza, R. Whitbourn, S. Windecker, H. M. Garcia-Garcia, E. Regar, and P. W. Serruys, “A comparative assessment by optical coherence tomography of the performance of the first and second generation of the everolimus-eluting bioresorbable vascular scaffolds,” Eur. Heart J. 32(3), 294–304 (2011).
[Crossref] [PubMed]

P. W. Serruys, Y. Onuma, J. A. Ormiston, B. de Bruyne, E. Regar, D. Dudek, L. Thuesen, P. C. Smits, B. Chevalier, D. McClean, J. Koolen, S. Windecker, R. Whitbourn, I. Meredith, C. Dorange, S. Veldhof, K. Miquel-Hebert, R. Rapoza, and H. M. García-García, “Evaluation of the second generation of a bioresorbable everolimus drug-eluting vascular scaffold for treatment of de novo coronary artery stenosis: six-month clinical and imaging outcomes,” Circulation 122(22), 2301–2312 (2010).
[Crossref] [PubMed]

N. Gonzalo, P. W. Serruys, N. Piazza, and E. Regar, “Optical coherence tomography (OCT) in secondary revascularisation: stent and graft assessment,” EuroIntervention 5(Suppl D), D93–D100 (2009).
[PubMed]

P. W. Serruys, J. A. Ormiston, Y. Onuma, E. Regar, N. Gonzalo, H. M. Garcia-Garcia, K. Nieman, N. Bruining, C. Dorange, K. Miquel-Hébert, S. Veldhof, M. Webster, L. Thuesen, and D. Dudek, “A bioabsorbable everolimus-eluting coronary stent system (ABSORB): 2-year outcomes and results from multiple imaging methods,” Lancet 373(9667), 897–910 (2009).
[Crossref] [PubMed]

Reiber, J. H.

A. Wang, J. Eggermont, N. Dekker, P. J. de Koning, J. H. Reiber, and J. Dijkstra, “3D assessment of stent cell size and side branch access in intravascular optical coherence tomographic pullback runs,” Comput. Med. Imaging Graph. 38(2), 113–122 (2014).
[Crossref] [PubMed]

A. Wang, J. Eggermont, N. Dekker, H. M. Garcia-Garcia, R. Pawar, J. H. Reiber, and J. Dijkstra, “Automatic stent strut detection in intravascular optical coherence tomographic pullback runs,” Int. J. Cardiovasc. Imaging 29(1), 29–38 (2013).
[Crossref] [PubMed]

Reiber, J. H. C.

A. Wang, J. Eggermont, N. Dekker, H. M. Garcia-Garcia, R. Pawar, J. H. C. Reiber, and J. Dijkstra, “A robust automated method to detect stent struts in 3D intravascular optical coherence tomographic image sequences,” Proc. SPIE 8315, 83150L (2012).
[Crossref]

Schmitt, J. M.

C. Xu, J. M. Schmitt, T. Akasaka, T. Kubo, and K. Huang, “Automatic detection of stent struts with thick neointimal growth in intravascular optical coherence tomography image sequences,” Phys. Med. Biol. 56(20), 6665–6675 (2011).
[Crossref] [PubMed]

Serruys, P.

A. Karanasos, C. Simsek, P. Serruys, J. Ligthart, K. Witberg, R. J. van Geuns, G. Sianos, F. Zijlstra, and E. Regar, “Five-year optical coherence tomography follow-up of an everolimus-eluting bioresorbable vascular scaffold: changing the paradigm of coronary stenting?” Circulation 126(7), e89–e91 (2012).
[Crossref] [PubMed]

Serruys, P. W.

D. Dudek, Y. Onuma, J. A. Ormiston, L. Thuesen, K. Miquel-Hebert, and P. W. Serruys, “Four-year clinical follow-up of the ABSORB everolimus-eluting bioresorbable vascular scaffold in patients with de novo coronary artery disease: the ABSORB trial,” EuroIntervention 7(9), 1060–1061 (2012).
[Crossref] [PubMed]

S. Brugaletta, H. M. Garcia-Garcia, Y. Onuma, and P. W. Serruys, “Everolimus-eluting ABSORB bioresorbable vascular scaffold: present and future perspectives,” Expert Rev. Med. Devices 9(4), 327–338 (2012).
[Crossref] [PubMed]

A. Sheehy, J. L. Gutiérrez-Chico, R. Diletti, J. P. Oberhauser, T. Glauser, J. Harrington, M. B. Kossuth, R. J. Rapoza, Y. Onuma, and P. W. Serruys, “In vivo characterisation of bioresorbable vascular scaffold strut interfaces using optical coherence tomography with Gaussian line spread function analysis,” EuroIntervention 7(10), 1227–1235 (2012).
[Crossref] [PubMed]

J. L. Gutiérrez-Chico, M. D. Radu, R. Diletti, A. Sheehy, M. B. Kossuth, J. P. Oberhauser, T. Glauser, J. Harrington, R. J. Rapoza, Y. Onuma, and P. W. Serruys, “Spatial distribution and temporal evolution of scattering centers by optical coherence tomography in the poly(L-lactide) backbone of a bioresorbable vascular scaffold,” Circ. J. 76(2), 342–350 (2012).
[Crossref] [PubMed]

B. D. Gogas, V. Farooq, Y. Onuma, and P. W. Serruys, “The ABSORB bioresorbable vascular scaffold: an evolution or revolution in interventional cardiology?” Hellenic J. Cardiol. 53(4), 301–309 (2012).
[PubMed]

J. Gomez-Lara, S. Brugaletta, R. Diletti, S. Garg, Y. Onuma, B. D. Gogas, R. J. van Geuns, C. Dorange, S. Veldhof, R. Rapoza, R. Whitbourn, S. Windecker, H. M. Garcia-Garcia, E. Regar, and P. W. Serruys, “A comparative assessment by optical coherence tomography of the performance of the first and second generation of the everolimus-eluting bioresorbable vascular scaffolds,” Eur. Heart J. 32(3), 294–304 (2011).
[Crossref] [PubMed]

P. W. Serruys, Y. Onuma, J. A. Ormiston, B. de Bruyne, E. Regar, D. Dudek, L. Thuesen, P. C. Smits, B. Chevalier, D. McClean, J. Koolen, S. Windecker, R. Whitbourn, I. Meredith, C. Dorange, S. Veldhof, K. Miquel-Hebert, R. Rapoza, and H. M. García-García, “Evaluation of the second generation of a bioresorbable everolimus drug-eluting vascular scaffold for treatment of de novo coronary artery stenosis: six-month clinical and imaging outcomes,” Circulation 122(22), 2301–2312 (2010).
[Crossref] [PubMed]

N. Gonzalo, P. W. Serruys, N. Piazza, and E. Regar, “Optical coherence tomography (OCT) in secondary revascularisation: stent and graft assessment,” EuroIntervention 5(Suppl D), D93–D100 (2009).
[PubMed]

P. W. Serruys, J. A. Ormiston, Y. Onuma, E. Regar, N. Gonzalo, H. M. Garcia-Garcia, K. Nieman, N. Bruining, C. Dorange, K. Miquel-Hébert, S. Veldhof, M. Webster, L. Thuesen, and D. Dudek, “A bioabsorbable everolimus-eluting coronary stent system (ABSORB): 2-year outcomes and results from multiple imaging methods,” Lancet 373(9667), 897–910 (2009).
[Crossref] [PubMed]

P. W. Serruys, A. T. Ong, J. J. Piek, F. J. Neumann, W. J. van der Giessen, M. Wiemer, A. Zeiher, E. Grube, J. Haase, L. Thuesen, C. Hamm, and P. C. Otto-Terlouw, “A randomized comparison of a durable polymer Everolimus-eluting stent with a bare metal coronary stent: The SPIRIT first trial,” EuroIntervention 1(1), 58–65 (2005).
[PubMed]

J. E. Sousa, P. W. Serruys, and M. A. Costa, “New frontiers in cardiology: drug-eluting stents: Part I,” Circulation 107(17), 2274–2279 (2003).
[Crossref] [PubMed]

Sheehy, A.

J. L. Gutiérrez-Chico, M. D. Radu, R. Diletti, A. Sheehy, M. B. Kossuth, J. P. Oberhauser, T. Glauser, J. Harrington, R. J. Rapoza, Y. Onuma, and P. W. Serruys, “Spatial distribution and temporal evolution of scattering centers by optical coherence tomography in the poly(L-lactide) backbone of a bioresorbable vascular scaffold,” Circ. J. 76(2), 342–350 (2012).
[Crossref] [PubMed]

A. Sheehy, J. L. Gutiérrez-Chico, R. Diletti, J. P. Oberhauser, T. Glauser, J. Harrington, M. B. Kossuth, R. J. Rapoza, Y. Onuma, and P. W. Serruys, “In vivo characterisation of bioresorbable vascular scaffold strut interfaces using optical coherence tomography with Gaussian line spread function analysis,” EuroIntervention 7(10), 1227–1235 (2012).
[Crossref] [PubMed]

Sianos, G.

A. Karanasos, C. Simsek, P. Serruys, J. Ligthart, K. Witberg, R. J. van Geuns, G. Sianos, F. Zijlstra, and E. Regar, “Five-year optical coherence tomography follow-up of an everolimus-eluting bioresorbable vascular scaffold: changing the paradigm of coronary stenting?” Circulation 126(7), e89–e91 (2012).
[Crossref] [PubMed]

Simsek, C.

A. Karanasos, C. Simsek, P. Serruys, J. Ligthart, K. Witberg, R. J. van Geuns, G. Sianos, F. Zijlstra, and E. Regar, “Five-year optical coherence tomography follow-up of an everolimus-eluting bioresorbable vascular scaffold: changing the paradigm of coronary stenting?” Circulation 126(7), e89–e91 (2012).
[Crossref] [PubMed]

Slabaugh, G.

G. Unal, S. Bucher, S. Carlier, G. Slabaugh, T. Fang, and K. Tanaka, “Shape-driven segmentation of the arterial wall in intravascular ultrasound images,” IEEE Trans. Inf. Technol. Biomed. 12(3), 335–347 (2008).
[Crossref] [PubMed]

Smits, P. C.

P. W. Serruys, Y. Onuma, J. A. Ormiston, B. de Bruyne, E. Regar, D. Dudek, L. Thuesen, P. C. Smits, B. Chevalier, D. McClean, J. Koolen, S. Windecker, R. Whitbourn, I. Meredith, C. Dorange, S. Veldhof, K. Miquel-Hebert, R. Rapoza, and H. M. García-García, “Evaluation of the second generation of a bioresorbable everolimus drug-eluting vascular scaffold for treatment of de novo coronary artery stenosis: six-month clinical and imaging outcomes,” Circulation 122(22), 2301–2312 (2010).
[Crossref] [PubMed]

Sousa, J. E.

J. E. Sousa, P. W. Serruys, and M. A. Costa, “New frontiers in cardiology: drug-eluting stents: Part I,” Circulation 107(17), 2274–2279 (2003).
[Crossref] [PubMed]

Stefanadis, C. I.

C. I. Stefanadis, “Stents for coronary artery disease: from covered to drug-eluting to bioabsorbable., ” Hellenic J. Cardiol. 53(1), 89–90 (2012).
[PubMed]

Stefanini, G. G.

B. Kalesan, T. Pilgrim, K. Heinimann, L. Räber, G. G. Stefanini, M. Valgimigli, B. R. da Costa, F. Mach, T. F. Lüscher, B. Meier, S. Windecker, and P. Jüni, “Comparison of drug-eluting stents with bare metal stents in patients with ST-segment elevation myocardial infarction,” Eur. Heart J. 33(8), 977–987 (2012).
[Crossref] [PubMed]

Tanaka, K.

G. Unal, S. Bucher, S. Carlier, G. Slabaugh, T. Fang, and K. Tanaka, “Shape-driven segmentation of the arterial wall in intravascular ultrasound images,” IEEE Trans. Inf. Technol. Biomed. 12(3), 335–347 (2008).
[Crossref] [PubMed]

Thuesen, L.

D. Dudek, Y. Onuma, J. A. Ormiston, L. Thuesen, K. Miquel-Hebert, and P. W. Serruys, “Four-year clinical follow-up of the ABSORB everolimus-eluting bioresorbable vascular scaffold in patients with de novo coronary artery disease: the ABSORB trial,” EuroIntervention 7(9), 1060–1061 (2012).
[Crossref] [PubMed]

P. W. Serruys, Y. Onuma, J. A. Ormiston, B. de Bruyne, E. Regar, D. Dudek, L. Thuesen, P. C. Smits, B. Chevalier, D. McClean, J. Koolen, S. Windecker, R. Whitbourn, I. Meredith, C. Dorange, S. Veldhof, K. Miquel-Hebert, R. Rapoza, and H. M. García-García, “Evaluation of the second generation of a bioresorbable everolimus drug-eluting vascular scaffold for treatment of de novo coronary artery stenosis: six-month clinical and imaging outcomes,” Circulation 122(22), 2301–2312 (2010).
[Crossref] [PubMed]

P. W. Serruys, J. A. Ormiston, Y. Onuma, E. Regar, N. Gonzalo, H. M. Garcia-Garcia, K. Nieman, N. Bruining, C. Dorange, K. Miquel-Hébert, S. Veldhof, M. Webster, L. Thuesen, and D. Dudek, “A bioabsorbable everolimus-eluting coronary stent system (ABSORB): 2-year outcomes and results from multiple imaging methods,” Lancet 373(9667), 897–910 (2009).
[Crossref] [PubMed]

P. W. Serruys, A. T. Ong, J. J. Piek, F. J. Neumann, W. J. van der Giessen, M. Wiemer, A. Zeiher, E. Grube, J. Haase, L. Thuesen, C. Hamm, and P. C. Otto-Terlouw, “A randomized comparison of a durable polymer Everolimus-eluting stent with a bare metal coronary stent: The SPIRIT first trial,” EuroIntervention 1(1), 58–65 (2005).
[PubMed]

Unal, G.

G. Unal, S. Gurmeric, and S. G. Carlier, “Stent implant follow-up in intravascular optical coherence tomography images,” Int. J. Cardiovasc. Imaging 26(7), 809–816 (2010).
[Crossref] [PubMed]

S. Gurmeric, G. G. Isguder, S. Carlier, and G. Unal, “A new 3-D automated computational method to evaluate in-stent neointimal hyperplasia in in-vivo intravascular optical coherence tomography pullbacks,” Med. Image Comput. Comput. Assist. Interv. 12(Pt 2), 776–785 (2009).
[PubMed]

G. Unal, S. Bucher, S. Carlier, G. Slabaugh, T. Fang, and K. Tanaka, “Shape-driven segmentation of the arterial wall in intravascular ultrasound images,” IEEE Trans. Inf. Technol. Biomed. 12(3), 335–347 (2008).
[Crossref] [PubMed]

Valgimigli, M.

B. Kalesan, T. Pilgrim, K. Heinimann, L. Räber, G. G. Stefanini, M. Valgimigli, B. R. da Costa, F. Mach, T. F. Lüscher, B. Meier, S. Windecker, and P. Jüni, “Comparison of drug-eluting stents with bare metal stents in patients with ST-segment elevation myocardial infarction,” Eur. Heart J. 33(8), 977–987 (2012).
[Crossref] [PubMed]

van der Giessen, W. J.

P. W. Serruys, A. T. Ong, J. J. Piek, F. J. Neumann, W. J. van der Giessen, M. Wiemer, A. Zeiher, E. Grube, J. Haase, L. Thuesen, C. Hamm, and P. C. Otto-Terlouw, “A randomized comparison of a durable polymer Everolimus-eluting stent with a bare metal coronary stent: The SPIRIT first trial,” EuroIntervention 1(1), 58–65 (2005).
[PubMed]

van Geuns, R. J.

A. Karanasos, C. Simsek, P. Serruys, J. Ligthart, K. Witberg, R. J. van Geuns, G. Sianos, F. Zijlstra, and E. Regar, “Five-year optical coherence tomography follow-up of an everolimus-eluting bioresorbable vascular scaffold: changing the paradigm of coronary stenting?” Circulation 126(7), e89–e91 (2012).
[Crossref] [PubMed]

J. Gomez-Lara, S. Brugaletta, R. Diletti, S. Garg, Y. Onuma, B. D. Gogas, R. J. van Geuns, C. Dorange, S. Veldhof, R. Rapoza, R. Whitbourn, S. Windecker, H. M. Garcia-Garcia, E. Regar, and P. W. Serruys, “A comparative assessment by optical coherence tomography of the performance of the first and second generation of the everolimus-eluting bioresorbable vascular scaffolds,” Eur. Heart J. 32(3), 294–304 (2011).
[Crossref] [PubMed]

Veldhof, S.

J. Gomez-Lara, S. Brugaletta, R. Diletti, S. Garg, Y. Onuma, B. D. Gogas, R. J. van Geuns, C. Dorange, S. Veldhof, R. Rapoza, R. Whitbourn, S. Windecker, H. M. Garcia-Garcia, E. Regar, and P. W. Serruys, “A comparative assessment by optical coherence tomography of the performance of the first and second generation of the everolimus-eluting bioresorbable vascular scaffolds,” Eur. Heart J. 32(3), 294–304 (2011).
[Crossref] [PubMed]

P. W. Serruys, Y. Onuma, J. A. Ormiston, B. de Bruyne, E. Regar, D. Dudek, L. Thuesen, P. C. Smits, B. Chevalier, D. McClean, J. Koolen, S. Windecker, R. Whitbourn, I. Meredith, C. Dorange, S. Veldhof, K. Miquel-Hebert, R. Rapoza, and H. M. García-García, “Evaluation of the second generation of a bioresorbable everolimus drug-eluting vascular scaffold for treatment of de novo coronary artery stenosis: six-month clinical and imaging outcomes,” Circulation 122(22), 2301–2312 (2010).
[Crossref] [PubMed]

P. W. Serruys, J. A. Ormiston, Y. Onuma, E. Regar, N. Gonzalo, H. M. Garcia-Garcia, K. Nieman, N. Bruining, C. Dorange, K. Miquel-Hébert, S. Veldhof, M. Webster, L. Thuesen, and D. Dudek, “A bioabsorbable everolimus-eluting coronary stent system (ABSORB): 2-year outcomes and results from multiple imaging methods,” Lancet 373(9667), 897–910 (2009).
[Crossref] [PubMed]

Wang, A.

A. Wang, J. Eggermont, N. Dekker, P. J. de Koning, J. H. Reiber, and J. Dijkstra, “3D assessment of stent cell size and side branch access in intravascular optical coherence tomographic pullback runs,” Comput. Med. Imaging Graph. 38(2), 113–122 (2014).
[Crossref] [PubMed]

A. Wang, J. Eggermont, N. Dekker, H. M. Garcia-Garcia, R. Pawar, J. H. Reiber, and J. Dijkstra, “Automatic stent strut detection in intravascular optical coherence tomographic pullback runs,” Int. J. Cardiovasc. Imaging 29(1), 29–38 (2013).
[Crossref] [PubMed]

A. Wang, J. Eggermont, N. Dekker, H. M. Garcia-Garcia, R. Pawar, J. H. C. Reiber, and J. Dijkstra, “A robust automated method to detect stent struts in 3D intravascular optical coherence tomographic image sequences,” Proc. SPIE 8315, 83150L (2012).
[Crossref]

Webster, M.

P. W. Serruys, J. A. Ormiston, Y. Onuma, E. Regar, N. Gonzalo, H. M. Garcia-Garcia, K. Nieman, N. Bruining, C. Dorange, K. Miquel-Hébert, S. Veldhof, M. Webster, L. Thuesen, and D. Dudek, “A bioabsorbable everolimus-eluting coronary stent system (ABSORB): 2-year outcomes and results from multiple imaging methods,” Lancet 373(9667), 897–910 (2009).
[Crossref] [PubMed]

Whitbourn, R.

J. Gomez-Lara, S. Brugaletta, R. Diletti, S. Garg, Y. Onuma, B. D. Gogas, R. J. van Geuns, C. Dorange, S. Veldhof, R. Rapoza, R. Whitbourn, S. Windecker, H. M. Garcia-Garcia, E. Regar, and P. W. Serruys, “A comparative assessment by optical coherence tomography of the performance of the first and second generation of the everolimus-eluting bioresorbable vascular scaffolds,” Eur. Heart J. 32(3), 294–304 (2011).
[Crossref] [PubMed]

P. W. Serruys, Y. Onuma, J. A. Ormiston, B. de Bruyne, E. Regar, D. Dudek, L. Thuesen, P. C. Smits, B. Chevalier, D. McClean, J. Koolen, S. Windecker, R. Whitbourn, I. Meredith, C. Dorange, S. Veldhof, K. Miquel-Hebert, R. Rapoza, and H. M. García-García, “Evaluation of the second generation of a bioresorbable everolimus drug-eluting vascular scaffold for treatment of de novo coronary artery stenosis: six-month clinical and imaging outcomes,” Circulation 122(22), 2301–2312 (2010).
[Crossref] [PubMed]

Wiemer, M.

P. W. Serruys, A. T. Ong, J. J. Piek, F. J. Neumann, W. J. van der Giessen, M. Wiemer, A. Zeiher, E. Grube, J. Haase, L. Thuesen, C. Hamm, and P. C. Otto-Terlouw, “A randomized comparison of a durable polymer Everolimus-eluting stent with a bare metal coronary stent: The SPIRIT first trial,” EuroIntervention 1(1), 58–65 (2005).
[PubMed]

Windecker, S.

B. Kalesan, T. Pilgrim, K. Heinimann, L. Räber, G. G. Stefanini, M. Valgimigli, B. R. da Costa, F. Mach, T. F. Lüscher, B. Meier, S. Windecker, and P. Jüni, “Comparison of drug-eluting stents with bare metal stents in patients with ST-segment elevation myocardial infarction,” Eur. Heart J. 33(8), 977–987 (2012).
[Crossref] [PubMed]

J. Gomez-Lara, S. Brugaletta, R. Diletti, S. Garg, Y. Onuma, B. D. Gogas, R. J. van Geuns, C. Dorange, S. Veldhof, R. Rapoza, R. Whitbourn, S. Windecker, H. M. Garcia-Garcia, E. Regar, and P. W. Serruys, “A comparative assessment by optical coherence tomography of the performance of the first and second generation of the everolimus-eluting bioresorbable vascular scaffolds,” Eur. Heart J. 32(3), 294–304 (2011).
[Crossref] [PubMed]

P. W. Serruys, Y. Onuma, J. A. Ormiston, B. de Bruyne, E. Regar, D. Dudek, L. Thuesen, P. C. Smits, B. Chevalier, D. McClean, J. Koolen, S. Windecker, R. Whitbourn, I. Meredith, C. Dorange, S. Veldhof, K. Miquel-Hebert, R. Rapoza, and H. M. García-García, “Evaluation of the second generation of a bioresorbable everolimus drug-eluting vascular scaffold for treatment of de novo coronary artery stenosis: six-month clinical and imaging outcomes,” Circulation 122(22), 2301–2312 (2010).
[Crossref] [PubMed]

Witberg, K.

A. Karanasos, C. Simsek, P. Serruys, J. Ligthart, K. Witberg, R. J. van Geuns, G. Sianos, F. Zijlstra, and E. Regar, “Five-year optical coherence tomography follow-up of an everolimus-eluting bioresorbable vascular scaffold: changing the paradigm of coronary stenting?” Circulation 126(7), e89–e91 (2012).
[Crossref] [PubMed]

Xu, C.

C. Xu, J. M. Schmitt, T. Akasaka, T. Kubo, and K. Huang, “Automatic detection of stent struts with thick neointimal growth in intravascular optical coherence tomography image sequences,” Phys. Med. Biol. 56(20), 6665–6675 (2011).
[Crossref] [PubMed]

Zeiher, A.

P. W. Serruys, A. T. Ong, J. J. Piek, F. J. Neumann, W. J. van der Giessen, M. Wiemer, A. Zeiher, E. Grube, J. Haase, L. Thuesen, C. Hamm, and P. C. Otto-Terlouw, “A randomized comparison of a durable polymer Everolimus-eluting stent with a bare metal coronary stent: The SPIRIT first trial,” EuroIntervention 1(1), 58–65 (2005).
[PubMed]

Zijlstra, F.

A. Karanasos, C. Simsek, P. Serruys, J. Ligthart, K. Witberg, R. J. van Geuns, G. Sianos, F. Zijlstra, and E. Regar, “Five-year optical coherence tomography follow-up of an everolimus-eluting bioresorbable vascular scaffold: changing the paradigm of coronary stenting?” Circulation 126(7), e89–e91 (2012).
[Crossref] [PubMed]

Circ. J. (1)

J. L. Gutiérrez-Chico, M. D. Radu, R. Diletti, A. Sheehy, M. B. Kossuth, J. P. Oberhauser, T. Glauser, J. Harrington, R. J. Rapoza, Y. Onuma, and P. W. Serruys, “Spatial distribution and temporal evolution of scattering centers by optical coherence tomography in the poly(L-lactide) backbone of a bioresorbable vascular scaffold,” Circ. J. 76(2), 342–350 (2012).
[Crossref] [PubMed]

Circulation (3)

P. W. Serruys, Y. Onuma, J. A. Ormiston, B. de Bruyne, E. Regar, D. Dudek, L. Thuesen, P. C. Smits, B. Chevalier, D. McClean, J. Koolen, S. Windecker, R. Whitbourn, I. Meredith, C. Dorange, S. Veldhof, K. Miquel-Hebert, R. Rapoza, and H. M. García-García, “Evaluation of the second generation of a bioresorbable everolimus drug-eluting vascular scaffold for treatment of de novo coronary artery stenosis: six-month clinical and imaging outcomes,” Circulation 122(22), 2301–2312 (2010).
[Crossref] [PubMed]

J. E. Sousa, P. W. Serruys, and M. A. Costa, “New frontiers in cardiology: drug-eluting stents: Part I,” Circulation 107(17), 2274–2279 (2003).
[Crossref] [PubMed]

A. Karanasos, C. Simsek, P. Serruys, J. Ligthart, K. Witberg, R. J. van Geuns, G. Sianos, F. Zijlstra, and E. Regar, “Five-year optical coherence tomography follow-up of an everolimus-eluting bioresorbable vascular scaffold: changing the paradigm of coronary stenting?” Circulation 126(7), e89–e91 (2012).
[Crossref] [PubMed]

Comput. Med. Imaging Graph. (1)

A. Wang, J. Eggermont, N. Dekker, P. J. de Koning, J. H. Reiber, and J. Dijkstra, “3D assessment of stent cell size and side branch access in intravascular optical coherence tomographic pullback runs,” Comput. Med. Imaging Graph. 38(2), 113–122 (2014).
[Crossref] [PubMed]

Eur. Heart J. (2)

J. Gomez-Lara, S. Brugaletta, R. Diletti, S. Garg, Y. Onuma, B. D. Gogas, R. J. van Geuns, C. Dorange, S. Veldhof, R. Rapoza, R. Whitbourn, S. Windecker, H. M. Garcia-Garcia, E. Regar, and P. W. Serruys, “A comparative assessment by optical coherence tomography of the performance of the first and second generation of the everolimus-eluting bioresorbable vascular scaffolds,” Eur. Heart J. 32(3), 294–304 (2011).
[Crossref] [PubMed]

B. Kalesan, T. Pilgrim, K. Heinimann, L. Räber, G. G. Stefanini, M. Valgimigli, B. R. da Costa, F. Mach, T. F. Lüscher, B. Meier, S. Windecker, and P. Jüni, “Comparison of drug-eluting stents with bare metal stents in patients with ST-segment elevation myocardial infarction,” Eur. Heart J. 33(8), 977–987 (2012).
[Crossref] [PubMed]

EuroIntervention (4)

P. W. Serruys, A. T. Ong, J. J. Piek, F. J. Neumann, W. J. van der Giessen, M. Wiemer, A. Zeiher, E. Grube, J. Haase, L. Thuesen, C. Hamm, and P. C. Otto-Terlouw, “A randomized comparison of a durable polymer Everolimus-eluting stent with a bare metal coronary stent: The SPIRIT first trial,” EuroIntervention 1(1), 58–65 (2005).
[PubMed]

D. Dudek, Y. Onuma, J. A. Ormiston, L. Thuesen, K. Miquel-Hebert, and P. W. Serruys, “Four-year clinical follow-up of the ABSORB everolimus-eluting bioresorbable vascular scaffold in patients with de novo coronary artery disease: the ABSORB trial,” EuroIntervention 7(9), 1060–1061 (2012).
[Crossref] [PubMed]

A. Sheehy, J. L. Gutiérrez-Chico, R. Diletti, J. P. Oberhauser, T. Glauser, J. Harrington, M. B. Kossuth, R. J. Rapoza, Y. Onuma, and P. W. Serruys, “In vivo characterisation of bioresorbable vascular scaffold strut interfaces using optical coherence tomography with Gaussian line spread function analysis,” EuroIntervention 7(10), 1227–1235 (2012).
[Crossref] [PubMed]

N. Gonzalo, P. W. Serruys, N. Piazza, and E. Regar, “Optical coherence tomography (OCT) in secondary revascularisation: stent and graft assessment,” EuroIntervention 5(Suppl D), D93–D100 (2009).
[PubMed]

Expert Rev. Med. Devices (1)

S. Brugaletta, H. M. Garcia-Garcia, Y. Onuma, and P. W. Serruys, “Everolimus-eluting ABSORB bioresorbable vascular scaffold: present and future perspectives,” Expert Rev. Med. Devices 9(4), 327–338 (2012).
[Crossref] [PubMed]

Hellenic J. Cardiol. (2)

C. I. Stefanadis, “Stents for coronary artery disease: from covered to drug-eluting to bioabsorbable., ” Hellenic J. Cardiol. 53(1), 89–90 (2012).
[PubMed]

B. D. Gogas, V. Farooq, Y. Onuma, and P. W. Serruys, “The ABSORB bioresorbable vascular scaffold: an evolution or revolution in interventional cardiology?” Hellenic J. Cardiol. 53(4), 301–309 (2012).
[PubMed]

IEEE Trans. Inf. Technol. Biomed. (1)

G. Unal, S. Bucher, S. Carlier, G. Slabaugh, T. Fang, and K. Tanaka, “Shape-driven segmentation of the arterial wall in intravascular ultrasound images,” IEEE Trans. Inf. Technol. Biomed. 12(3), 335–347 (2008).
[Crossref] [PubMed]

Int. J. Cardiovasc. Imaging (2)

A. Wang, J. Eggermont, N. Dekker, H. M. Garcia-Garcia, R. Pawar, J. H. Reiber, and J. Dijkstra, “Automatic stent strut detection in intravascular optical coherence tomographic pullback runs,” Int. J. Cardiovasc. Imaging 29(1), 29–38 (2013).
[Crossref] [PubMed]

G. Unal, S. Gurmeric, and S. G. Carlier, “Stent implant follow-up in intravascular optical coherence tomography images,” Int. J. Cardiovasc. Imaging 26(7), 809–816 (2010).
[Crossref] [PubMed]

Lancet (2)

A. Grüntzig, “Transluminal dilatation of coronary-artery stenosis,” Lancet 311(8058), 263 (1978).
[Crossref] [PubMed]

P. W. Serruys, J. A. Ormiston, Y. Onuma, E. Regar, N. Gonzalo, H. M. Garcia-Garcia, K. Nieman, N. Bruining, C. Dorange, K. Miquel-Hébert, S. Veldhof, M. Webster, L. Thuesen, and D. Dudek, “A bioabsorbable everolimus-eluting coronary stent system (ABSORB): 2-year outcomes and results from multiple imaging methods,” Lancet 373(9667), 897–910 (2009).
[Crossref] [PubMed]

Med. Image Comput. Comput. Assist. Interv. (1)

S. Gurmeric, G. G. Isguder, S. Carlier, and G. Unal, “A new 3-D automated computational method to evaluate in-stent neointimal hyperplasia in in-vivo intravascular optical coherence tomography pullbacks,” Med. Image Comput. Comput. Assist. Interv. 12(Pt 2), 776–785 (2009).
[PubMed]

Numer. Math. (1)

E. W. Dijkstra, “A note on two problems in connexion with graphs,” Numer. Math. 1(1), 269–271 (1959).
[Crossref]

Phys. Med. Biol. (1)

C. Xu, J. M. Schmitt, T. Akasaka, T. Kubo, and K. Huang, “Automatic detection of stent struts with thick neointimal growth in intravascular optical coherence tomography image sequences,” Phys. Med. Biol. 56(20), 6665–6675 (2011).
[Crossref] [PubMed]

Proc. SPIE (1)

A. Wang, J. Eggermont, N. Dekker, H. M. Garcia-Garcia, R. Pawar, J. H. C. Reiber, and J. Dijkstra, “A robust automated method to detect stent struts in 3D intravascular optical coherence tomographic image sequences,” Proc. SPIE 8315, 83150L (2012).
[Crossref]

Other (2)

J. M. S. Prewitt, “Object enhancement and extraction,” in Picture Processing and Psychopictorics, B. S. Lipkin, ed. (Academic Press, New York, 1970), pp. 75–149.

W. K. Pratt, Digital Image Processing (John Wiley & Sons, Inc., 1978), p. 750.

Cited By

OSA participates in Crossref's Cited-By Linking service. Citing articles from OSA journals and other participating publishers are listed here.

Alert me when this article is cited.


Figures (9)

Fig. 1
Fig. 1 A baseline IVOCT image in (a) the Cartesian coordinate system and (b) the polar coordinate system. In both images, the imaging catheter (IC), the protective sheath (PS), the guide wire, a micro vessel and a BVS strut are marked.
Fig. 2
Fig. 2 The flow chart of the BVS strut detection method.
Fig. 3
Fig. 3 The detected imaging catheter (dashed straight line “1”), protective sheath (solid curve “2”) and guide wire shadow region (area “3”) are given in figure (a). The masked image is given in figure (b). Inside the protective sheath, it is masked with the background intensity value, while the guide wire shadow region is masked as 0.
Fig. 4
Fig. 4 The gradient images of a baseline image and a follow-up image are given in figures (a) and (b). They are used for lumen detection. Yellow curves indicate the detected minimal cost paths. In figures (c) and (d), the original polar images are presented with lumen contours (white curves). The new polar images transformed based on the lumen center are shown in figures (e) and (f) in which most of the BVS struts are more rectangular than in original polar images.
Fig. 5
Fig. 5 Figures (a) and (b) show a scan-line (white line) passing through a BVS strut in a baseline image and a follow up image, respectively. The corresponding gradient images are presented in figures (c) and (d). The intensity profile (yellow curve) and the gradient profile (white curve) are given in figures (e) and (f). A BVS strut always has low intensity values in the black core region and strong gradient values along the boundary.
Fig. 6
Fig. 6 Figure (a) shows a new polar baseline image that is transformed based on the center of a highly irregular lumen contour. The BVS struts in figure (a) still appear distorted and their thickness in the vertical direction is very different. Figure (b) demonstrates a follow-up image transformed based on the center of a circular lumen contour. The BVS struts are less distorted than these in figure (a). The detected candidate line segments (short white lines) are presented in both figures (c) and (d). Both white and black arrows point out the candidate segments caused by residual blood or noise in tissue. These candidates will be clustered as false candidate strut during the clustering. After the false positive removal, only real struts are left as figures (e) and (f) shows.
Fig. 7
Fig. 7 The original boundaries of clusters formed by white points in figure (a) and the smoothed boundaries in figure (b).
Fig. 8
Fig. 8 Figure (a) shows the smoothed boundaries of a cluster in yellow dots. In figure (b), two white lines are fitted to the top part of the strut boundary and two light blue lines are fitted to the bottom part of the strut boundary. Along the fitted lines, the missed boundaries in the sharp tip regions are recovered as figure (c) demonstrated and the final refined strut contour is generated as (d) presents.
Fig. 9
Fig. 9 Figure (a) shows two black cores marked by the first observer and they were marked as a big strut by the second observer as figure (b) presents. A comparison of the ground truth (solid white contours) from the second observer and the algorithmic results (dashed yellow contour with white translucent mask) in a baseline image is presented in figure (c) and another comparison of the ground truth from the first observer and the algorithmic results in a follow-up image is given in figure (d). The enlarged images of the white rectangle regions are given in figures (e) and (f).

Tables (2)

Tables Icon

Table 1 The strut detection results of the presented method for each validation data set. For each data set, the number of frames containing struts (Frame No.), the numbers of struts in the ground truth (GT), the percentages of true positive (TP) and false positive (FP) are given

Tables Icon

Table 2 The strut area measurement performance of the present method in each validation data set. The area of the ground truth (GT) and the Dice’s coefficient between the ground truth and the algorithmic results are given for all struts and only successfully detected struts

Metrics